Annals of Cardiology is a peer-reviewed open-access journal dedicated to propelling the field of cardiology forward. We focus on publishing top-tier research and expert clinical perspectives to advance cardiovascular medicine. Our journal serves as a platform for sharing groundbreaking studies, clinical innovations, and educational resources in cardiovascular health. By promoting high-quality research and fostering collaboration among researchers, clinicians, and health professionals, we aim to enhance the understanding, prevention, and treatment of cardiovascular diseases worldwide.
Read MoreAnomalous Aortic Origin of Coronary Arteries (AAOCA) occurs in approximately 0.64% of the population. It represents the second leading cause of Sudden Cardiac Death (SCD) in adolescents, following hypertrophic cardiomyopathy. The risk of SCD is estimated to be around 6.3% from an Anomalous Aortic Origin of the Left Coronary Artery (AAOLCA) and 0.2% from an anomalous Aortic Origin of the Right Coronary Artery (AAORCA).
In many patients undergoing Coronary Artery Bypass Graft surgery (CABG), venous Saphenous (SVG) is used in addition to the arterial grafts. Treatment of degenerated and occluded venous graft is complex and challenging. Angioplasty on occluded venous bypass involves a high rate of complications (such as massive distal embolization)...
Severe acute respiratory syndrome is the new coronavirus responsible for the coronavirus disease 2019 (COVID-19), which was declared a global public health emergency by the World Health Organization on March 11, 20 [1-3]. As for COVID-19 updated registry, 422 million confirmed cases have been reported globally to for February 2022, with 5 million deaths worldwide...
Illustration of the effects of selective Aldosterone Synthase Inhibitors (ASIs) in patients with resistant or uncontrolled Hypertension (HTN). ASIs significantly reduce systolic blood pressure (SBP, Mean Difference [MD] –8.44 mmHg; 95% Confidence Interval ...
Despite reductions in the incidence and mortality of Cardiovascular Disease (CVD) in the last decades it still accounts over 30% of worldwide death. Although females experience higher mortality the clinical IHD guidelines do not distinguish between sexes and despite added diagnostic procedures the differences remain.
